Skip to main content
. 2020 Sep 24;26:e926651-1–e926651-12. doi: 10.12659/MSM.926651

Figure 1.

Figure 1

Survival analysis before (A) and after (B) propensity score matching of COVID-19 patients complicated with hypertension. ACEIs – angiotensin-converting enzyme inhibitors; ARBs – angiotensin II receptor blockers.